 | • レポートコード：MRC2-11QY12365 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、133ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は感染症検査のグローバル市場について調査・分析したレポートです。種類別（分子診断検査、POCT、免疫診断検査）市場規模、用途別（HIV、呼吸器、HAI、性的健康、熱帯病、肝炎）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別感染症検査の競争状況、市場シェア ・世界の感染症検査市場：種類別市場規模 2015年-2020年（分子診断検査、POCT、免疫診断検査） ・世界の感染症検査市場：種類別市場規模予測 2021年-2026年（分子診断検査、POCT、免疫診断検査） ・世界の感染症検査市場：用途別市場規模 2015年-2020年（HIV、呼吸器、HAI、性的健康、熱帯病、肝炎） ・世界の感染症検査市場：用途別市場規模予測 2021年-2026年（HIV、呼吸器、HAI、性的健康、熱帯病、肝炎） ・北米の感染症検査市場分析：米国、カナダ ・ヨーロッパの感染症検査市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの感染症検査市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の感染症検査市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの感染症検査市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott Diagnostics、Abbott、Beckman Coulter Diagnostics、Roche、Siemens Healthcare、Abaxis、Acon Laboratories、Avioq、BD、Bio-Rad Laboratories、Cavidi、Cepheid、Chembio Diagnostic Systems、Clarity Diagnostics、EMD Millipore、Epitope Diagnostic、Gold Standard Diagnostics、Hologic、Immunetics、InBios International、Life Technologies、Maxim Biomedical ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
In hospitals, infectious disease specialists help ensure the timely diagnosis and treatment of acute infections by recommending the appropriate diagnostic tests to identify the source of the infection and by recommending the appropriate antibiotic to treat the infection.
Biochemical tests used in the identification of infectious agents include the detection of metabolic or enzymatic products characteristic of a particular infectious agent. Since bacteria ferment carbohydrates in patterns characteristic of their genus and species, the detection of fermentation products is commonly used in bacterial identification. Acids, alcohols and gases are usually detected in these tests when bacteria are grown in selective liquid or solid media.
Market Analysis and Insights: Global Infectious Disease Testing Market
The global Infectious Disease Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Infectious Disease Testing Scope and Market Size
Infectious Disease Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Infectious Disease Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott Diagnostics
Abbott
Beckman Coulter Diagnostics
Roche
Siemens Healthcare
Abaxis
Acon Laboratories
Avioq
BD
Bio-Rad Laboratories
Cavidi
Cepheid
Chembio Diagnostic Systems
Clarity Diagnostics
EMD Millipore
Epitope Diagnostic
Gold Standard Diagnostics
Hologic
Immunetics
InBios International
Life Technologies
Maxim Biomedical
Market segment by Type, the product can be split into
Molecular diagnostic test
POCT
Immunodiagnostic test
Market segment by Application, split into
HIV
Respiratory
HAIs
Sexual health
Tropical diseases
Hepatitis
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Infectious Disease Testing Revenue
1.4 Market by Type
1.4.1 Global Infectious Disease Testing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Molecular diagnostic test
1.4.3 POCT
1.4.4 Immunodiagnostic test
1.5 Market by Application
1.5.1 Global Infectious Disease Testing Market Share by Application: 2020 VS 2026
1.5.2 HIV
1.5.3 Respiratory
1.5.4 HAIs
1.5.5 Sexual health
1.5.6 Tropical diseases
1.5.7 Hepatitis
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Infectious Disease Testing Market Perspective (2015-2026)
2.2 Global Infectious Disease Testing Growth Trends by Regions
2.2.1 Infectious Disease Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Infectious Disease Testing Historic Market Share by Regions (2015-2020)
2.2.3 Infectious Disease Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Infectious Disease Testing Market Growth Strategy
2.3.6 Primary Interviews with Key Infectious Disease Testing Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Infectious Disease Testing Players by Market Size
3.1.1 Global Top Infectious Disease Testing Players by Revenue (2015-2020)
3.1.2 Global Infectious Disease Testing Revenue Market Share by Players (2015-2020)
3.1.3 Global Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Infectious Disease Testing Market Concentration Ratio
3.2.1 Global Infectious Disease Testing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Infectious Disease Testing Revenue in 2019
3.3 Infectious Disease Testing Key Players Head office and Area Served
3.4 Key Players Infectious Disease Testing Product Solution and Service
3.5 Date of Enter into Infectious Disease Testing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Infectious Disease Testing Historic Market Size by Type (2015-2020)
4.2 Global Infectious Disease Testing Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Infectious Disease Testing Market Size by Application (2015-2020)
5.2 Global Infectious Disease Testing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Infectious Disease Testing Market Size (2015-2020)
6.2 Infectious Disease Testing Key Players in North America (2019-2020)
6.3 North America Infectious Disease Testing Market Size by Type (2015-2020)
6.4 North America Infectious Disease Testing Market Size by Application (2015-2020)
7 Europe
7.1 Europe Infectious Disease Testing Market Size (2015-2020)
7.2 Infectious Disease Testing Key Players in Europe (2019-2020)
7.3 Europe Infectious Disease Testing Market Size by Type (2015-2020)
7.4 Europe Infectious Disease Testing Market Size by Application (2015-2020)
8 China
8.1 China Infectious Disease Testing Market Size (2015-2020)
8.2 Infectious Disease Testing Key Players in China (2019-2020)
8.3 China Infectious Disease Testing Market Size by Type (2015-2020)
8.4 China Infectious Disease Testing Market Size by Application (2015-2020)
9 Japan
9.1 Japan Infectious Disease Testing Market Size (2015-2020)
9.2 Infectious Disease Testing Key Players in Japan (2019-2020)
9.3 Japan Infectious Disease Testing Market Size by Type (2015-2020)
9.4 Japan Infectious Disease Testing Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Infectious Disease Testing Market Size (2015-2020)
10.2 Infectious Disease Testing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Infectious Disease Testing Market Size by Type (2015-2020)
10.4 Southeast Asia Infectious Disease Testing Market Size by Application (2015-2020)
11 India
11.1 India Infectious Disease Testing Market Size (2015-2020)
11.2 Infectious Disease Testing Key Players in India (2019-2020)
11.3 India Infectious Disease Testing Market Size by Type (2015-2020)
11.4 India Infectious Disease Testing Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Infectious Disease Testing Market Size (2015-2020)
12.2 Infectious Disease Testing Key Players in Central & South America (2019-2020)
12.3 Central & South America Infectious Disease Testing Market Size by Type (2015-2020)
12.4 Central & South America Infectious Disease Testing Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott Diagnostics
13.1.1 Abbott Diagnostics Company Details
13.1.2 Abbott Diagnostics Business Overview
13.1.3 Abbott Diagnostics Infectious Disease Testing Introduction
13.1.4 Abbott Diagnostics Revenue in Infectious Disease Testing Business (2015-2020))
13.1.5 Abbott Diagnostics Recent Development
13.2 Abbott
13.2.1 Abbott Company Details
13.2.2 Abbott Business Overview
13.2.3 Abbott Infectious Disease Testing Introduction
13.2.4 Abbott Revenue in Infectious Disease Testing Business (2015-2020)
13.2.5 Abbott Recent Development
13.3 Beckman Coulter Diagnostics
13.3.1 Beckman Coulter Diagnostics Company Details
13.3.2 Beckman Coulter Diagnostics Business Overview
13.3.3 Beckman Coulter Diagnostics Infectious Disease Testing Introduction
13.3.4 Beckman Coulter Diagnostics Revenue in Infectious Disease Testing Business (2015-2020)
13.3.5 Beckman Coulter Diagnostics Recent Development
13.4 Roche
13.4.1 Roche Company Details
13.4.2 Roche Business Overview
13.4.3 Roche Infectious Disease Testing Introduction
13.4.4 Roche Revenue in Infectious Disease Testing Business (2015-2020)
13.4.5 Roche Recent Development
13.5 Siemens Healthcare
13.5.1 Siemens Healthcare Company Details
13.5.2 Siemens Healthcare Business Overview
13.5.3 Siemens Healthcare Infectious Disease Testing Introduction
13.5.4 Siemens Healthcare Revenue in Infectious Disease Testing Business (2015-2020)
13.5.5 Siemens Healthcare Recent Development
13.6 Abaxis
13.6.1 Abaxis Company Details
13.6.2 Abaxis Business Overview
13.6.3 Abaxis Infectious Disease Testing Introduction
13.6.4 Abaxis Revenue in Infectious Disease Testing Business (2015-2020)
13.6.5 Abaxis Recent Development
13.7 Acon Laboratories
13.7.1 Acon Laboratories Company Details
13.7.2 Acon Laboratories Business Overview
13.7.3 Acon Laboratories Infectious Disease Testing Introduction
13.7.4 Acon Laboratories Revenue in Infectious Disease Testing Business (2015-2020)
13.7.5 Acon Laboratories Recent Development
13.8 Avioq
13.8.1 Avioq Company Details
13.8.2 Avioq Business Overview
13.8.3 Avioq Infectious Disease Testing Introduction
13.8.4 Avioq Revenue in Infectious Disease Testing Business (2015-2020)
13.8.5 Avioq Recent Development
13.9 BD
13.9.1 BD Company Details
13.9.2 BD Business Overview
13.9.3 BD Infectious Disease Testing Introduction
13.9.4 BD Revenue in Infectious Disease Testing Business (2015-2020)
13.9.5 BD Recent Development
13.10 Bio-Rad Laboratories
13.10.1 Bio-Rad Laboratories Company Details
13.10.2 Bio-Rad Laboratories Business Overview
13.10.3 Bio-Rad Laboratories Infectious Disease Testing Introduction
13.10.4 Bio-Rad Laboratories Revenue in Infectious Disease Testing Business (2015-2020)
13.10.5 Bio-Rad Laboratories Recent Development
13.11 Cavidi
10.11.1 Cavidi Company Details
10.11.2 Cavidi Business Overview
10.11.3 Cavidi Infectious Disease Testing Introduction
10.11.4 Cavidi Revenue in Infectious Disease Testing Business (2015-2020)
10.11.5 Cavidi Recent Development
13.12 Cepheid
10.12.1 Cepheid Company Details
10.12.2 Cepheid Business Overview
10.12.3 Cepheid Infectious Disease Testing Introduction
10.12.4 Cepheid Revenue in Infectious Disease Testing Business (2015-2020)
10.12.5 Cepheid Recent Development
13.13 Chembio Diagnostic Systems
10.13.1 Chembio Diagnostic Systems Company Details
10.13.2 Chembio Diagnostic Systems Business Overview
10.13.3 Chembio Diagnostic Systems Infectious Disease Testing Introduction
10.13.4 Chembio Diagnostic Systems Revenue in Infectious Disease Testing Business (2015-2020)
10.13.5 Chembio Diagnostic Systems Recent Development
13.14 Clarity Diagnostics
10.14.1 Clarity Diagnostics Company Details
10.14.2 Clarity Diagnostics Business Overview
10.14.3 Clarity Diagnostics Infectious Disease Testing Introduction
10.14.4 Clarity Diagnostics Revenue in Infectious Disease Testing Business (2015-2020)
10.14.5 Clarity Diagnostics Recent Development
13.15 EMD Millipore
10.15.1 EMD Millipore Company Details
10.15.2 EMD Millipore Business Overview
10.15.3 EMD Millipore Infectious Disease Testing Introduction
10.15.4 EMD Millipore Revenue in Infectious Disease Testing Business (2015-2020)
10.15.5 EMD Millipore Recent Development
13.16 Epitope Diagnostic
10.16.1 Epitope Diagnostic Company Details
10.16.2 Epitope Diagnostic Business Overview
10.16.3 Epitope Diagnostic Infectious Disease Testing Introduction
10.16.4 Epitope Diagnostic Revenue in Infectious Disease Testing Business (2015-2020)
10.16.5 Epitope Diagnostic Recent Development
13.17 Gold Standard Diagnostics
10.17.1 Gold Standard Diagnostics Company Details
10.17.2 Gold Standard Diagnostics Business Overview
10.17.3 Gold Standard Diagnostics Infectious Disease Testing Introduction
10.17.4 Gold Standard Diagnostics Revenue in Infectious Disease Testing Business (2015-2020)
10.17.5 Gold Standard Diagnostics Recent Development
13.18 Hologic
10.18.1 Hologic Company Details
10.18.2 Hologic Business Overview
10.18.3 Hologic Infectious Disease Testing Introduction
10.18.4 Hologic Revenue in Infectious Disease Testing Business (2015-2020)
10.18.5 Hologic Recent Development
13.19 Immunetics
10.19.1 Immunetics Company Details
10.19.2 Immunetics Business Overview
10.19.3 Immunetics Infectious Disease Testing Introduction
10.19.4 Immunetics Revenue in Infectious Disease Testing Business (2015-2020)
10.19.5 Immunetics Recent Development
13.20 InBios International
10.20.1 InBios International Company Details
10.20.2 InBios International Business Overview
10.20.3 InBios International Infectious Disease Testing Introduction
10.20.4 InBios International Revenue in Infectious Disease Testing Business (2015-2020)
10.20.5 InBios International Recent Development
13.21 Life Technologies
10.21.1 Life Technologies Company Details
10.21.2 Life Technologies Business Overview
10.21.3 Life Technologies Infectious Disease Testing Introduction
10.21.4 Life Technologies Revenue in Infectious Disease Testing Business (2015-2020)
10.21.5 Life Technologies Recent Development
13.22 Maxim Biomedical
10.22.1 Maxim Biomedical Company Details
10.22.2 Maxim Biomedical Business Overview
10.22.3 Maxim Biomedical Infectious Disease Testing Introduction
10.22.4 Maxim Biomedical Revenue in Infectious Disease Testing Business (2015-2020)
10.22.5 Maxim Biomedical Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Infectious Disease Testing Key Market Segments
Table 2. Key Players Covered: Ranking by Infectious Disease Testing Revenue
Table 3. Ranking of Global Top Infectious Disease Testing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Infectious Disease Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Molecular diagnostic test
Table 6. Key Players of POCT
Table 7. Key Players of Immunodiagnostic test
Table 8. Global Infectious Disease Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Infectious Disease Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Infectious Disease Testing Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Infectious Disease Testing Market Share by Regions (2015-2020)
Table 12. Global Infectious Disease Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Infectious Disease Testing Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Infectious Disease Testing Market Growth Strategy
Table 18. Main Points Interviewed from Key Infectious Disease Testing Players
Table 19. Global Infectious Disease Testing Revenue by Players (2015-2020) (Million US$)
Table 20. Global Infectious Disease Testing Market Share by Players (2015-2020)
Table 21. Global Top Infectious Disease Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease Testing as of 2019)
Table 22. Global Infectious Disease Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Infectious Disease Testing Product Solution and Service
Table 25. Date of Enter into Infectious Disease Testing Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Infectious Disease Testing Market Size by Type (2015-2020) (Million US$)
Table 28. Global Infectious Disease Testing Market Size Share by Type (2015-2020)
Table 29. Global Infectious Disease Testing Revenue Market Share by Type (2021-2026)
Table 30. Global Infectious Disease Testing Market Size Share by Application (2015-2020)
Table 31. Global Infectious Disease Testing Market Size by Application (2015-2020) (Million US$)
Table 32. Global Infectious Disease Testing Market Size Share by Application (2021-2026)
Table 33. North America Key Players Infectious Disease Testing Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Infectious Disease Testing Market Share (2019-2020)
Table 35. North America Infectious Disease Testing Market Size by Type (2015-2020) (Million US$)
Table 36. North America Infectious Disease Testing Market Share by Type (2015-2020)
Table 37. North America Infectious Disease Testing Market Size by Application (2015-2020) (Million US$)
Table 38. North America Infectious Disease Testing Market Share by Application (2015-2020)
Table 39. Europe Key Players Infectious Disease Testing Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Infectious Disease Testing Market Share (2019-2020)
Table 41. Europe Infectious Disease Testing Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Infectious Disease Testing Market Share by Type (2015-2020)
Table 43. Europe Infectious Disease Testing Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Infectious Disease Testing Market Share by Application (2015-2020)
Table 45. China Key Players Infectious Disease Testing Revenue (2019-2020) (Million US$)
Table 46. China Key Players Infectious Disease Testing Market Share (2019-2020)
Table 47. China Infectious Disease Testing Market Size by Type (2015-2020) (Million US$)
Table 48. China Infectious Disease Testing Market Share by Type (2015-2020)
Table 49. China Infectious Disease Testing Market Size by Application (2015-2020) (Million US$)
Table 50. China Infectious Disease Testing Market Share by Application (2015-2020)
Table 51. Japan Key Players Infectious Disease Testing Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Infectious Disease Testing Market Share (2019-2020)
Table 53. Japan Infectious Disease Testing Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Infectious Disease Testing Market Share by Type (2015-2020)
Table 55. Japan Infectious Disease Testing Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Infectious Disease Testing Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Infectious Disease Testing Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Infectious Disease Testing Market Share (2019-2020)
Table 59. Southeast Asia Infectious Disease Testing Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Infectious Disease Testing Market Share by Type (2015-2020)
Table 61. Southeast Asia Infectious Disease Testing Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Infectious Disease Testing Market Share by Application (2015-2020)
Table 63. India Key Players Infectious Disease Testing Revenue (2019-2020) (Million US$)
Table 64. India Key Players Infectious Disease Testing Market Share (2019-2020)
Table 65. India Infectious Disease Testing Market Size by Type (2015-2020) (Million US$)
Table 66. India Infectious Disease Testing Market Share by Type (2015-2020)
Table 67. India Infectious Disease Testing Market Size by Application (2015-2020) (Million US$)
Table 68. India Infectious Disease Testing Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Infectious Disease Testing Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Infectious Disease Testing Market Share (2019-2020)
Table 71. Central & South America Infectious Disease Testing Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Infectious Disease Testing Market Share by Type (2015-2020)
Table 73. Central & South America Infectious Disease Testing Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Infectious Disease Testing Market Share by Application (2015-2020)
Table 75. Abbott Diagnostics Company Details
Table 76. Abbott Diagnostics Business Overview
Table 77. Abbott Diagnostics Product
Table 78. Abbott Diagnostics Revenue in Infectious Disease Testing Business (2015-2020) (Million US$)
Table 79. Abbott Diagnostics Recent Development
Table 80. Abbott Company Details
Table 81. Abbott Business Overview
Table 82. Abbott Product
Table 83. Abbott Revenue in Infectious Disease Testing Business (2015-2020) (Million US$)
Table 84. Abbott Recent Development
Table 85. Beckman Coulter Diagnostics Company Details
Table 86. Beckman Coulter Diagnostics Business Overview
Table 87. Beckman Coulter Diagnostics Product
Table 88. Beckman Coulter Diagnostics Revenue in Infectious Disease Testing Business (2015-2020) (Million US$)
Table 89. Beckman Coulter Diagnostics Recent Development
Table 90. Roche Company Details
Table 91. Roche Business Overview
Table 92. Roche Product
Table 93. Roche Revenue in Infectious Disease Testing Business (2015-2020) (Million US$)
Table 94. Roche Recent Development
Table 95. Siemens Healthcare Company Details
Table 96. Siemens Healthcare Business Overview
Table 97. Siemens Healthcare Product
Table 98. Siemens Healthcare Revenue in Infectious Disease Testing Business (2015-2020) (Million US$)
Table 99. Siemens Healthcare Recent Development
Table 100. Abaxis Company Details
Table 101. Abaxis Business Overview
Table 102. Abaxis Product
Table 103. Abaxis Revenue in Infectious Disease Testing Business (2015-2020) (Million US$)
Table 104. Abaxis Recent Development
Table 105. Acon Laboratories Company Details
Table 106. Acon Laboratories Business Overview
Table 107. Acon Laboratories Product
Table 108. Acon Laboratories Revenue in Infectious Disease Testing Business (2015-2020) (Million US$)
Table 109. Acon Laboratories Recent Development
Table 110. Avioq Business Overview
Table 111. Avioq Product
Table 112. Avioq Company Details
Table 113. Avioq Revenue in Infectious Disease Testing Business (2015-2020) (Million US$)
Table 114. Avioq Recent Development
Table 115. BD Company Details
Table 116. BD Business Overview
Table 117. BD Product
Table 118. BD Revenue in Infectious Disease Testing Business (2015-2020) (Million US$)
Table 119. BD Recent Development
Table 120. Bio-Rad Laboratories Company Details
Table 121. Bio-Rad Laboratories Business Overview
Table 122. Bio-Rad Laboratories Product
Table 123. Bio-Rad Laboratories Revenue in Infectious Disease Testing Business (2015-2020) (Million US$)
Table 124. Bio-Rad Laboratories Recent Development
Table 125. Cavidi Company Details
Table 126. Cavidi Business Overview
Table 127. Cavidi Product
Table 128. Cavidi Revenue in Infectious Disease Testing Business (2015-2020) (Million US$)
Table 129. Cavidi Recent Development
Table 130. Cepheid Company Details
Table 131. Cepheid Business Overview
Table 132. Cepheid Product
Table 133. Cepheid Revenue in Infectious Disease Testing Business (2015-2020) (Million US$)
Table 134. Cepheid Recent Development
Table 135. Chembio Diagnostic Systems Company Details
Table 136. Chembio Diagnostic Systems Business Overview
Table 137. Chembio Diagnostic Systems Product
Table 138. Chembio Diagnostic Systems Revenue in Infectious Disease Testing Business (2015-2020) (Million US$)
Table 139. Chembio Diagnostic Systems Recent Development
Table 140. Clarity Diagnostics Company Details
Table 141. Clarity Diagnostics Business Overview
Table 142. Clarity Diagnostics Product
Table 143. Clarity Diagnostics Revenue in Infectious Disease Testing Business (2015-2020) (Million US$)
Table 144. Clarity Diagnostics Recent Development
Table 145. EMD Millipore Company Details
Table 146. EMD Millipore Business Overview
Table 147. EMD Millipore Product
Table 148. EMD Millipore Revenue in Infectious Disease Testing Business (2015-2020) (Million US$)
Table 149. EMD Millipore Recent Development
Table 150. Epitope Diagnostic Company Details
Table 151. Epitope Diagnostic Business Overview
Table 152. Epitope Diagnostic Product
Table 153. Epitope Diagnostic Revenue in Infectious Disease Testing Business (2015-2020) (Million US$)
Table 154. Epitope Diagnostic Recent Development
Table 155. Gold Standard Diagnostics Company Details
Table 156. Gold Standard Diagnostics Business Overview
Table 157. Gold Standard Diagnostics Product
Table 158. Gold Standard Diagnostics Revenue in Infectious Disease Testing Business (2015-2020) (Million US$)
Table 159. Gold Standard Diagnostics Recent Development
Table 160. Hologic Company Details
Table 161. Hologic Business Overview
Table 162. Hologic Product
Table 163. Hologic Revenue in Infectious Disease Testing Business (2015-2020) (Million US$)
Table 164. Hologic Recent Development
Table 165. Immunetics Company Details
Table 166. Immunetics Business Overview
Table 167. Immunetics Product
Table 168. Immunetics Revenue in Infectious Disease Testing Business (2015-2020) (Million US$)
Table 169. Immunetics Recent Development
Table 170. InBios International Company Details
Table 171. InBios International Business Overview
Table 172. InBios International Product
Table 173. InBios International Revenue in Infectious Disease Testing Business (2015-2020) (Million US$)
Table 174. InBios International Recent Development
Table 175. Life Technologies Company Details
Table 176. Life Technologies Business Overview
Table 177. Life Technologies Product
Table 178. Life Technologies Revenue in Infectious Disease Testing Business (2015-2020) (Million US$)
Table 179. Life Technologies Recent Development
Table 180. Maxim Biomedical Company Details
Table 181. Maxim Biomedical Business Overview
Table 182. Maxim Biomedical Product
Table 183. Maxim Biomedical Revenue in Infectious Disease Testing Business (2015-2020) (Million US$)
Table 184. Maxim Biomedical Recent Development
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Infectious Disease Testing Market Share by Type: 2020 VS 2026
Figure 2. Molecular diagnostic test Features
Figure 3. POCT Features
Figure 4. Immunodiagnostic test Features
Figure 5. Global Infectious Disease Testing Market Share by Application: 2020 VS 2026
Figure 6. HIV Case Studies
Figure 7. Respiratory Case Studies
Figure 8. HAIs Case Studies
Figure 9. Sexual health Case Studies
Figure 10. Tropical diseases Case Studies
Figure 11. Hepatitis Case Studies
Figure 12. Infectious Disease Testing Report Years Considered
Figure 13. Global Infectious Disease Testing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Infectious Disease Testing Market Share by Regions: 2020 VS 2026
Figure 15. Global Infectious Disease Testing Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Infectious Disease Testing Market Share by Players in 2019
Figure 18. Global Top Infectious Disease Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease Testing as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Infectious Disease Testing Revenue in 2019
Figure 20. North America Infectious Disease Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Infectious Disease Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Infectious Disease Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Infectious Disease Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Infectious Disease Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Infectious Disease Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Infectious Disease Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed
感染症診断検査の世界市場（～2026年） Market Analysis and Insights: Global Infectious Disease Diagnostic Testing Market The global Infectious Disease Diagnostic Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Infectious Disease Diagnostic Testing S…- 感染症検査における分子診断の世界市場（～2026年） Molecular diagnostics is a technique used to detect the presence of and identify genetic materials and proteins associated with specific health conditions and diseases, and infectious agents in body fluids such as blood, urine, or sputum. Molecular diagnostics for infectious disease testing is used …
- 獣医感染症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Veterinary Infectious Disease Therapeutics Market The global Veterinary Infectious Disease Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Veterinary Infectious Disease…
- 呼吸器疾患検査/診断の世界市場（～2026年） Respiratory measuring devices, also known as respirometers, include respirometers, pulse oximeters, carbonic acid meters, and peak flow meters. The prevalence of respiratory diseases such as chronic obstructive pulmonary disease, asthma and other respiratory infections, as well as the increasing pop…
- 感染症治療の世界市場（～2026年） Treatment for Infectious Diseases. Treatment of viral infections such as HIV involves patient care and moral support including antiretroviral therapy. Bacterial infections can be treated by administering antibiotics to the patients. Market Analysis and Insights: Global Infectious Disease Treatment M…